Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Johns Hopkins University
Study ID
NCT07828613
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Extremity Fracture Lower
  • Extremity Injuries Lower
  • Open Dislocation of Ankle
  • Open Tibia Fracture

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Accelerated Flap Coverage Surgery — PROCEDURE
    Activation of the accelerated flap pathway with a goal flap time of \<72h from injury
  • Standard of Care Flap Timing — PROCEDURE
    Flap timing at the standard of care timing for the clinical site

Study Details

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with open fractures and/or dislocations below the knee. Eligible patients will be randomized to receive either a flap within a goal of 72 hours of injury or standard of care flap timing for the institution. The primary outcome will be a composite outcome to evaluate clinical status 6 months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) amputation related to injury, 3) re-operation for infection and/or flap complication (flap compromise, partial and/or complete flap failure), and 4) days in hospital, defined as days in an acute in-patient hospital (i.e., not rehab or nursing facility).

Key Dates

First listed
Sep 18, 2026
Start date
Jan 1, 2027
Status verified
Sep 2026
Primary completion
Jul 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
356 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Accelerated Flap Coverage
    Accelerated flap surgery timing at a goal of within 72 hours from injury. Management of the fracture or dislocation, selection of flap, and post-injury flap management will be at the discretion of the operating surgeons and documented for both treatment groups.
  • Active Comparator: Standard of Care Flap Timing
    The flap surgery will be performed at the standard of care timing for the institution. Management of the fracture or dislocation, selection of flap, and post-injury flap management will be at the discretion of the operating surgeons and documented for both treatment groups.

Primary Outcome Measure

Clinical Status [ Time Frame: 6 months ]

Central Contacts

Locations (31)

FacilityCityStateZIPSite coordinators
Banner - University Medical Center PhoenixPhoenixArizona85006
Michael McKee, MD
602-839-2000
Cedars-Sinai Medical CenterLos AngelesCalifornia90084
Geoffrey Marecek, MD
310-423-3277
Keck Hospital of USCLos AngelesCalifornia90033
Joseph Patterson, MD
800-872-2273
Los Angeles Medical CenterLos AngelesCalifornia90033
Joseph Patterson, MD
323-409-1000
UC Davis Medical CenterSacramentoCalifornia95817
Ara Salibian, MD
916-734-2011
UC San Diego HealthSan DiegoCalifornia92121
Kathryn Dwight, MD
858-657-8737
Yale New Haven HospitalNew HavenConnecticut06510
David Colen, MD
203-688-4242
University of Chicago MedicineChicagoIllinois60637
Maureen Beederman, MD
888-824-0200
IU Health University HospitalIndianapolisIndiana46202
Erin Weber, MD
317-944-5000
Louisiana State University Health Sciences CenterNew OrleansLouisiana70112
Jessica Rivera, MD
504-568-4808
Johns Hopkins HospitalBaltimoreMaryland21287
Lily Mundy
410-706-2492
Johns Hopkins Hospital - Bayview Medical CenterBaltimoreMaryland21224
Lily Mundy, MD
410-550-0100
University of Maryland - Shock Trauma CenterBaltimoreMaryland21201
Mark Gage, MD
410-448-6400
University of Maryland - Capital RegionLargoMaryland20774
Mark Gage, MD
240-677-1000
Brigham and Women's HospitalBostonMassachusetts02115
Lydia Helliwell, MD
617-732-5500
University of Mississippi Medical CenterJacksonMississippi39216
Patrick Bergin, MD
601-984-1000
University of Missouri HospitalColumbiaMissouri65212
Gregory Della Rocca
573-882-4141
University of Nebraska Medical CenterOmahaNebraska68198
Andrew Hollins, MD
402-559-4000
Jamaica Hospital Medical CenterThe BronxNew York11418
Abhishek Ganta, MD
718-206-6000
University of Cincinnati Medical CenterCincinnatiOhio45219
Michael Beltran, MD
513-584-1000
Ohio State University Wexner Medical CenterColumbusOhio43221
Angela Collins
614-293-5084
Miami Valley HospitalDaytonOhio45409
Michael Johnson, MD
937-208-8000
Oregon Health & Science UniversityPortlandOregon97239
Graham DeKeyser, MD
503-494-8311
Brown University HealthProvidenceRhode Island02903
Franca Kraenzlin, MD
401-444-3500
Vanderbilt University Medical CenterNashvilleTennessee37232
Lauren Tatman, MD
615-322-5000
The University of Texas Health Science Center at HoustonHoustonTexas77030
Mohin Bhadkamkar, MD
713-500-4472
University of Utah HospitalSalt Lake CityUtah84132
Lucas Marchand, MD
801-581-2121
Inova Fairfax HospitalFalls ChurchVirginia22042
Abraham Goch, MD
703-776-4001
UW Medical CenterSeattleWashington98195
Jeffrey Friedrich, MD
206-598-3300
University of Wisconsin Health University HospitalMadisonWisconsin53792
Christopher Domes, MD
608-263-6400
Medical College of WisconsinMilwaukeeWisconsin53226
Elizabeth Harkin, MD
414-955-8296

Find similar trials in Phoenix, AZ

Related Studies